CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 91 enrolled
Drug / intervention
A4i Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04602741
NCT04602741N/ACompleted

Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement

Centre for Addiction and Mental Health·interventional·Posted Oct 26, 2020·Updated May 22, 2026

In Brief

A clinical study evaluating A4i Intervention for Schizophrenia and 2 related conditions. Completed, enrolled 91 participants across 1 site.

Detailed Summary

The effective treatment of schizophrenia is very challenging due to a number of factors. These include issues such as poor engagement with treatment plans and care providers, limited contacts with providers due to under-resourced health services, and the challenges inherent to schizophrenia symptoms. The outcomes of these problems include frequent, lengthy, and costly hospital readmissions, low quality of life, high levels of distress, and difficulties engaging in valued community roles. Digital Health technologies are a promising model to help address these problems. They are a low cost and accessible form of support and have not been substantively developed or studied for people with schizophrenia spectrum illnesses. In this study, the feasibility of one such technology that is in development will be tested: App4Independence (A4i). A4i provides customized coping prompts, peer-peer networking, and a portal that facilitates better provider engagement. This research will provide critical information in the development of this new technology to address a key problem in the field - how to enhance care in a resource-limited context where provider-patient contacts are brief, infrequent, and rely on in the moment recall and self-advocacy by patients. These findings will lay the groundwork for a larger program of research and software development that will (i) validate the technology across multiple sites and, (ii) catalyze engagement with healthcare systems and caregiver networks to scale-out access to this promising resource.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 26, 2020
Enrollment StartJan 4, 2021
Primary CompletionJun 1, 2023
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 5.7 years ago

Interventions

A4i Interventionbehavioral

6 months of the provision of A4i on the individual's own device.